We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+12.05%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.54B
AUM Growth
+$180M
Cap. Flow
-$52.8M
Cap. Flow %
-2.08%
Top 10 Hldgs %
14.42%
Holding
447
New
36
Increased
127
Reduced
198
Closed
42

Top Buys

Rank Stock Value
1
BKR icon
Baker Hughes
BKR
+$8.64M
2
HOG icon
Harley-Davidson
HOG
+$7.42M
3
ENOV icon
Enovis
ENOV
+$6.85M
4
PATK icon
Patrick Industries
PATK
+$6.08M
5
AAPL icon
Apple
AAPL
+$6.07M

Sector Composition

Rank Sector Weight
1 Technology 19.13%
2 Financials 15.93%
3 Healthcare 13.09%
4 Industrials 12.25%
5 Consumer Discretionary 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
376
TETRA Technologies
TTI
$1.27B
$451K 0.02%
130,346
-133,874
-51% -$521K
AVNW icon
377
Aviat Networks
AVNW
$273M
$446K 0.02%
+14,280
New +$434K
PGC icon
378
Peapack-Gladstone Financial
PGC
$802M
$437K 0.02%
+11,743
New +$448K
INSM icon
379
Insmed
INSM
$29.1B
$435K 0.02%
21,769
+1,240
+6% +$24K
SEE
380
DELISTED
Sealed Air
SEE
$420K 0.02%
8,427
-6,617
-44% -$323K
AGG icon
381
iShares Core US Aggregate Bond ETF
AGG
$138B
$395K 0.02%
4,070
SLQD icon
382
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$379K 0.01%
7,910
IMVT icon
383
Immunovant
IMVT
$8.18B
$377K 0.01%
+21,265
New +$268K
RARE icon
384
Ultragenyx Pharmaceutical
RARE
$2.59B
$374K 0.01%
8,085
+462
+6% +$18.2K
GIS icon
385
General Mills
GIS
$19.8B
$359K 0.01%
4,278
-458
-10% -$37.3K
SYNA icon
386
Synaptics
SYNA
$4.13B
$354K 0.01%
3,717
+211
+6% +$20.3K
SWKS icon
387
Skyworks Solutions
SWKS
$10.4B
$316K 0.01%
3,468
BHVN icon
388
Biohaven
BHVN
$2.22B
$313K 0.01%
+22,592
New +$319K
OMC icon
389
Omnicom Group
OMC
$22.9B
$313K 0.01%
3,837
-323
-8% -$24K
LYFT icon
390
Lyft
LYFT
$6.49B
$307K 0.01%
27,846
-5,531
-17% -$66.7K
J icon
391
Jacobs Solutions
J
$17.2B
$302K 0.01%
3,038
-242
-7% -$23.8K
IWN icon
392
iShares Russell 2000 Value ETF
IWN
$14.5B
$298K 0.01%
+2,150
New +$304K
BLU
393
DELISTED
BELLUS Health Inc.
BLU
$294K 0.01%
35,691
+2,035
+6% +$19K
CMCSA icon
394
Comcast
CMCSA
$88.6B
$248K 0.01%
+7,097
New +$235K
CVS icon
395
CVS Health
CVS
$122B
$246K 0.01%
2,644
-50,966
-95% -$4.92M
XLE icon
396
State Street Energy Select Sector SPDR ETF
XLE
$38.9B
$207K 0.01%
+4,728
New +$206K
FRC
397
DELISTED
First Republic Bank
FRC
$207K 0.01%
1,695
-156
-8% -$19K
LQDA icon
398
Liquidia Corp
LQDA
$7.94B
$197K 0.01%
31,024
+1,769
+6% +$9.51K
AFMD
399
DELISTED
Affimed
AFMD
-13,220
Closed -$272K
AMED
400
DELISTED
Amedisys
AMED
-11,086
Closed -$1.07M

Similar funds

Chartwell Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Chartwell Investment Partners held 447 positions worth $2.54B, up 7.7% from $2.36B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Chartwell Investment Partners's Q4 2022 filing shows 36 new, 127 increased, 198 reduced and 42 closed positions. Its largest new stake was Harley-Davidson: 174,365 shares worth $7.25M. The largest sale was LHC Group LLC, an estimated $15.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q4 2022 buy was Harley-Davidson: 174,365 shares worth $7.25M.
  • Chartwell Investment Partners added most to Baker Hughes in Q4 2022, an estimated $8.64M increase.
  • Chartwell Investment Partners's biggest Q4 2022 reduction was Pioneer Natural Resource Co., cutting an estimated $7.85M.
  • Chartwell Investment Partners fully exited LHC Group LLC in Q4 2022, selling an estimated $15.3M.
  • Chartwell Investment Partners's ten largest holdings make up 14% of its $2.54B portfolio in Q4 2022.
  • Chartwell Investment Partners opened 36 new positions and closed 42 in Q4 2022.
  • Chartwell Investment Partners's portfolio value rose 7.7% quarter-over-quarter to $2.54B.

Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.